Primary immune thrombocytopenia: Understanding pathogenesis is the key to better treatments

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 2, 2009, Pages 319-321

  Chong, Beng H ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD40 LIGAND MONOCLONAL ANTIBODY; CORTICOSTEROID; ELTHROMBOPAG; FC RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HLA ANTIGEN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT THROMBOPOIETIN; RHESUS D ANTIBODY; RITUXIMAB; ROMIPLOSTIM; THROMBIN RECEPTOR; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ASEPTIC MENINGITIS; AUTOIMMUNE THROMBOCYTOPENIA; B LYMPHOCYTE; BONE MARROW SUPPRESSION; CELL INTERACTION; CROSS REACTION; CYTOKINE RELEASE; DRUG BINDING; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; HEMOLYSIS; HUMAN; IMMUNOPATHOGENESIS; INFECTION; NAUSEA; NEUTROPENIA; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THROMBOCYTOPOIESIS; UNSPECIFIED SIDE EFFECT; VOMITING;

AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTES;

EID: 59049094431     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03258.x     Document Type: Note

References (28)

1. Harrington WJ, Minnich V, Hollingsworth JW, Moore JC. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951; 38: 1-10.
2. Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocyotpenias. Blood 1996; 88: 194-201.
3. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb/ IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 1998; 102: 1393-402.
4. Kuwana M, Okazaki Y, Ikeda Y. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura. J Thromb Haemost 2009; 7: 322-9.
5. Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA. Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br J Haematol 2003; 120: 135-41.
6. Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991; 45: 9-17.
7. Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kawakami Y, Ikeda Y. Immunodominant epitopes on glycoprotein.IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood 2001; 98: 130-9.
8. Kuwana M, Kawakami Y, Ikeda Y. Suppresson of autoreactive T cell response to glycoprotein IIb-IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura. Blood 2003; 101: 621-3.
9. McMillan R, Lopez-Dee J, Bowditch R. Clonal restriction of platelet-associated anti-GPIIb/IIIa autoantibody in patients with chronic ITP. Thromb Haemost 2001; 85: 821-3.
10. Roark JH, Bussel JB, Cines DB, Siegel DL. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood 2002; 100: 1388-98.
11. Zhou B, Zhao H, Yang RC, Han ZC. Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol 2005; 54: 107-16.
12. Jonuleit H, Schmitt E. The regulatory T cell family: Distinct subsets and their interactions. J Immunol 2003; 171: 6323-7.
13. Imbach P, Kuhne T. Immune thrombocytopenic purpura, ITP. Vox Sang 1998; 74 (Suppl): 309-14.
14. Solanilla A, Pasquet JM, Viallard JF, Contin C, Grosset C, Dechanet-Merville J, Dupouy M, Landry M, Belloc F, Nurden P, Blanco P, Moreau JF, Pellegrin JL, Nurden AT, Ripoche J. Platelet-associated CD 154 in immune thrombocytopenic purpura. Blood 2005; 105: 215-8.
15. Semple JW. T cell and cytokine abnormalities in patients with autoimmune thrombocytopenic purpura. Transfus Apheresis Sci 2003; 28: 237-42.
16. Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, Maniatis A, Mouzaki A. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarised immune response. Blood 2004; 103: 2645-7.
17. Olsson B, Andersson P-O, Jernas M, Jacobsson S, Carlsson B, Carlsson LM, Wadenvik H. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003; 9: 1123-4.
18. Bellem PJ, Segal GM, Stratton JR, Gersheimer T, Adamson JW, Slichter SJ. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: Evidence for both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 67: 86-92.
19. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult chronic ITP patients. Blood 2004; 103: 1364-9.
20. Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, Nugent DJ. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in.vitro. Blood 2003; 102: 887-95.
21. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001; 97: 812-14.
22. Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes B, Wolfel EE, Mestroni L, Page RL, Kobashigawa J. Drug therapy in the heart transplant recIpient: Part II: immunosuppressive drugs. Circulation 2004; 110: 3858-65.
23. Howard J, Hoffbrand AV, Prentice HG, Mehta A. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anemia and auto-immune thrombocytopenia purpura. Br J Haeamatol 2002; 177: 712-15.
24. Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG. Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007; 146: 25-33.
25. Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management. Thromb Haemost 2008; 99: 4-13.
26. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with ITP. Blood 2004; 104: 2623-34.
27. Kuter DJ, Bussel JB, Lyons RM, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrere F et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double blind randomized controlled trial. Lancet 2008; 371: 395-403.
28. Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, Kloczko J, Hassani H, Mayer B, Stone NL, Arning M, Provan D, Jenkins MJ. Elthrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357: 2237-47.